Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 20,000,000
    Countries
    Sector(s)
    Belgium : € 20,000,000
    Industry : € 20,000,000
    Signature date(s)
    25/07/2025 : € 20,000,000

    Summary sheet

    Release date
    4 June 2025
    Status
    Reference
    Signed | 25/07/2025
    20240551
    Project name
    Promoter - financial intermediary
    SAMANTREE (IEU LS)
    ACCEPTABLE CORPORATE(S)
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 20 million
    EUR 56 million
    Location
    Sector(s)
    Description
    Objectives

    The project supports the development of an advanced microscopy scanner for rapid imaging of the internal microstructure of tissue samples for interventional oncology.

    The aim of the project is to support the development of the RDI activities of the promoter, including development and improvement of the Histolog® Scanner, a microscopy device that provides real-time imaging of the internal microstructure of tissue samples for interventional oncology.

    Additionality and Impact

    The operation contributes to the InvestEU objective of research, development, and innovation. The purpose of the loan is to provide direct, equity-type financing under the EIB's Venture Debt Instrument to support research, development, and innovation (RDI) activities of an innovative Belgian MedTech company focused on advancing an innovative microscopy device for real-time imaging of tissue samples in the context of interventional oncology. The financing of this project addresses the failure in financial markets for RDI, arising from limited access to commensurate financing due to factors such as information asymmetries, misalignment of incentives, etc. By creating knowledge externalities, the project is expected to provide significant socio-economic benefits, strengthen Belgium and Europe's position in the field of medical devices, and help create and retain skilled staff. Thanks to the support of InvestEU, the EIB may provide long-term financing in the form of venture debt to a highly innovative company with no access to commercial debt. By contributing to extending the cash runway and, therefore, de-risking the development plan of the company, EIB financing is expected to attract third-party investors and accelerate the company's development. The project would not have been carried out (to the same extent) by the EIB without the support of InvestEU.

    Environmental aspects
    Procurement

    The specific RDI activities included in the project are expected to be performed in existing facilities without changing their already authorised scope. Therefore, the project activities would not require an Environmental Impact Assessment (EIA) under the Directive 2014/52/EU amending the Directive 2011/52/EU. Full environmental details will be verified during appraisal.

    The promoter is a private company not operating in the utilities sector and not having the status of a contracting authority. Thus, it is generally not covered by EU directives on procurement. However, the Bank will require that all project contracts are procured in accordance with the applicable EU procurement legislation. The Bank's services will verify details during the project due diligence.

    Milestone
    Under appraisal
    Approved
    Signed
    18 June 2025
    25 July 2025
    Related projects

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - SAMANTREE (IEU LS)
    Publication Date
    5 Jul 2025
    Document language
    Main Topic
    Lending
    Document Number
    234220815
    Document Focus
    Environmental Information
    Project Number
    20240551
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications